Developing PEGylated Reversed D-Peptide as a Novel HER2-Targeted SPECT Imaging Probe for Breast Cancer DetectionBIOCONJUGATE CHEMISTRYIF3.92020-07-1325PREAI
An Integrin Alpha 6-Targeted Radiotracer with Improved Receptor Binding Affinity and Tumor UptakeBIOCONJUGATE CHEMISTRYIF3.92020-04-298PREAI
Clinicopathological and prognostic significance of CXCR4 high expression in renal cell carcinoma: A meta-analysis and literature reviewINTERNATIONAL JOURNAL OF SURGERYIF10.12019-11-016OAAI
Improved in Vivo Targeting Capability and Pharmacokinetics of 99mTc-Labeled isoDGR by Dimerization and Albumin-Binding for Glioma ImagingBIOCONJUGATE CHEMISTRYIF3.92019-05-0720PREAI
Lectin-Mediated pH-Sensitive Doxorubicin Prodrug for Pre-Targeted Chemotherapy of Colorectal Cancer with Enhanced Efficacy and Reduced Side EffectsTHERANOSTICSIF13.32019-01-0126OAAI
Hyaluronic Acid-Coated Silver Nanoparticles As a Nanoplatform for in Vivo Imaging ApplicationsACS APPLIED MATERIALS & INTERFACESIF8.22016-09-2137PREAI
Small-Animal SPECT/CT of the Progression and Recovery of Rat Liver Fibrosis by Using an Integrin αvβ3-targeting RadiotracerRADIOLOGYIF15.22016-05-0124PRE
SPECT/NIRF Dual Modality Imaging for Detection of Intraperitoneal Colon Tumor with an Avidin/Biotin Pretargeting SystemSCIENTIFIC REPORTSIF3.92016-01-0621OAAI
68Ga-Labeled 3PRGD2 for Dual PET and Cerenkov Luminescence Imaging of Orthotopic Human GlioblastomaBIOCONJUGATE CHEMISTRYIF3.92015-05-1224PREAI
Early Assessment of Tumor Response to Gefitinib Treatment by Noninvasive Optical Imaging of Tumor Vascular Endothelial Growth Factor Expression in Animal ModelsJOURNAL OF NUCLEAR MEDICINEIF9.12014-03-1720OAAI
Longitudinal monitoring of tumor antiangiogenic therapy with near-infrared fluorophore-labeled agents targeted to integrin αvβ3 and vascular endothelial growth factorEuropean Journal of Nuclear Medicine and Molecular ImagingIF7.62014-02-2212PRE
Anti-tumor Effect of Integrin Targeted 177Lu-3PRGD2 and Combined Therapy with EndostarTHERANOSTICSIF13.32014-01-0130OAAI
Epidermal Growth Factor Receptor-Targeted Radioimmunotherapy of Human Head and Neck Cancer Xenografts Using 90Y-Labeled Fully Human Antibody PanitumumabMOLECULAR CANCER THERAPEUTICSIF5.52010-08-0927OAAI
Blood Clearance Kinetics, Biodistribution, and Radiation Dosimetry of a Kit-Formulated Integrin αvβ3-Selective Radiotracer 99mTc-3PRGD2 in Non-Human PrimatesMOLECULAR IMAGING AND BIOLOGYIF2.52010-08-0683PREAI
Specific Targeting of Human Integrin αvβ3 with 111In-Labeled Abegrin™ in Nude Mouse ModelsMOLECULAR IMAGING AND BIOLOGYIF2.52010-04-1024OA
Tumor Uptake of the RGD Dimeric Probe 99mTc-G3-2P4-RGD2 is Correlated with Integrin αvβ3 Expressed on both Tumor Cells and NeovasculatureBIOCONJUGATE CHEMISTRYIF3.92010-02-2556PREAI
Radioimmunotherapy of Human Colon Cancer Xenografts with 131I-Labeled Anti-CEA Monoclonal AntibodyBIOCONJUGATE CHEMISTRYIF3.92010-01-1521PREAI
Potential therapeutic radiotracers: preparation, biodistribution and metabolic characteristics of 177Lu-labeled cyclic RGDfK dimerAMINO ACIDSIF2.42009-11-2620PREAI
Linker effects on biological properties of 111In-Labeled DTPA conjugates of a cyclic RGDfK dimerBIOCONJUGATE CHEMISTRYIF3.92007-12-1152OAAI
99mTc-labeled cyclic RGDfK dimer:: Initial evaluation for SPECT imaging of glioma integrin αvβ3 expressionBIOCONJUGATE CHEMISTRYIF3.92006-06-2979PREAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项